These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 15120188)

  • 1. Functional promoter region polymorphism of the proinflammatory chemokine IL-8 gene associates with Parkinson's disease in the Irish.
    Ross OA; O'Neill C; Rea IM; Lynch T; Gosal D; Wallace A; Curran MD; Middleton D; Gibson JM
    Hum Immunol; 2004 Apr; 65(4):340-6. PubMed ID: 15120188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of genes coding for inflammatory components in Parkinson's disease.
    Håkansson A; Westberg L; Nilsson S; Buervenich S; Carmine A; Holmberg B; Sydow O; Olson L; Johnels B; Eriksson E; Nissbrandt H
    Mov Disord; 2005 May; 20(5):569-73. PubMed ID: 15648059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different methylation of the TNF-alpha promoter in cortex and substantia nigra: Implications for selective neuronal vulnerability.
    Pieper HC; Evert BO; Kaut O; Riederer PF; Waha A; Wüllner U
    Neurobiol Dis; 2008 Dec; 32(3):521-7. PubMed ID: 18930140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of association between IL-1β, TNF-α, and IL-10 gene polymorphisms and sporadic Parkinson's disease in an Italian cohort.
    Pascale E; Passarelli E; Purcaro C; Vestri AR; Fakeri A; Guglielmi R; Passarelli F; Meco G
    Acta Neurol Scand; 2011 Sep; 124(3):176-81. PubMed ID: 20880267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-10 (IL10) and tumor necrosis factor alpha (TNF) gene polymorphisms in Parkinson's disease patients.
    Bialecka M; Klodowska-Duda G; Kurzawski M; Slawek J; Gorzkowska A; Opala G; Bialecki P; Sagan L; Droździk M
    Parkinsonism Relat Disord; 2008 Dec; 14(8):636-40. PubMed ID: 18362084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The transcription factor PITX3 is associated with sporadic Parkinson's disease.
    Fuchs J; Mueller JC; Lichtner P; Schulte C; Munz M; Berg D; Wüllner U; Illig T; Sharma M; Gasser T
    Neurobiol Aging; 2009 May; 30(5):731-8. PubMed ID: 17905480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic polymorphism of interleukin-8 (IL-8) is associated with Helicobacter pylori-induced duodenal ulcer.
    Gyulai Z; Klausz G; Tiszai A; Lénárt Z; Kása IT; Lonovics J; Mándi Y
    Eur Cytokine Netw; 2004; 15(4):353-8. PubMed ID: 15627645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of association between the interleukin-1 alpha (-889) polymorphism and early-onset Parkinson's disease.
    Möller JC; Depboylu C; Kölsch H; Lohmüller F; Bandmann O; Gocke P; Du Y; Paus S; Wüllner U; Gasser T; Oertel WH; Klockgether T; Dodel RC
    Neurosci Lett; 2004 Apr; 359(3):195-7. PubMed ID: 15050696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of tau gene polymorphism with age at onset of Parkinson's disease.
    Kobayashi H; Ujike H; Hasegawa J; Yamamoto M; Kanzaki A; Sora I
    Neurosci Lett; 2006 Sep; 405(3):202-6. PubMed ID: 16876320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of a promoter polymorphism on the transcription of nitric oxide synthase 1 and its relevance to Parkinson's disease.
    Rife T; Rasoul B; Pullen N; Mitchell D; Grathwol K; Kurth J
    J Neurosci Res; 2009 Aug; 87(10):2319-25. PubMed ID: 19326438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple candidate gene analysis identifies alpha-synuclein as a susceptibility gene for sporadic Parkinson's disease.
    Mizuta I; Satake W; Nakabayashi Y; Ito C; Suzuki S; Momose Y; Nagai Y; Oka A; Inoko H; Fukae J; Saito Y; Sawabe M; Murayama S; Yamamoto M; Hattori N; Murata M; Toda T
    Hum Mol Genet; 2006 Apr; 15(7):1151-8. PubMed ID: 16500997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between chronic hepatitis B virus infection and interleukin-10, tumor necrosis factor-alpha gene promoter polymorphisms.
    Cheong JY; Cho SW; Hwang IL; Yoon SK; Lee JH; Park CS; Lee JE; Hahm KB; Kim JH
    J Gastroenterol Hepatol; 2006 Jul; 21(7):1163-9. PubMed ID: 16824070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. alpha-Synuclein and Parkinson disease susceptibility.
    Winkler S; Hagenah J; Lincoln S; Heckman M; Haugarvoll K; Lohmann-Hedrich K; Kostic V; Farrer M; Klein C
    Neurology; 2007 Oct; 69(18):1745-50. PubMed ID: 17872362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A single nucleotide polymorphism in the matrix metalloproteinase-1 and interleukin-8 gene promoter predicts poor prognosis in tongue cancer.
    Shimizu Y; Kondo S; Shirai A; Furukawa M; Yoshizaki T
    Auris Nasus Larynx; 2008 Sep; 35(3):381-9. PubMed ID: 18276095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular implications of the human glutathione transferase A-4 gene (hGSTA4) polymorphisms in neurodegenerative diseases.
    Coppedè F; Armani C; Bidia DD; Petrozzi L; Bonuccelli U; Migliore L
    Mutat Res; 2005 Nov; 579(1-2):107-14. PubMed ID: 16054170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-6 and IL-10 promoter gene polymorphisms do not associate with the susceptibility for multiple myeloma.
    Mazur G; Bogunia-Kubik K; Wróbel T; Karabon L; Polak M; Kuliczkowski K; Lange A
    Immunol Lett; 2005 Jan; 96(2):241-6. PubMed ID: 15585329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic analysis of lysosomal alpha-galactosidase A gene in sporadic Parkinson's disease.
    Wu G; Pang S; Feng X; Zhang A; Li J; Gu K; Huang J; Dong H; Yan B
    Neurosci Lett; 2011 Aug; 500(1):31-5. PubMed ID: 21683120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of cytokine gene polymorphisms in determining disease susceptibility and phenotype in inflammatory bowel disease.
    Cantor MJ; Nickerson P; Bernstein CN
    Am J Gastroenterol; 2005 May; 100(5):1134-42. PubMed ID: 15842590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Frequency of the IVS4+66A-G polymorphism in the alpha-synuclein gene in patients with Parkinson's disease in north-western Mexico].
    Ramírez-Jirano LJ; Ruiz-Sandoval JL; Jiménez-Gil FJ; Ramírez-Vega J; Vargas-Frutos E; Gallegos-Arreola MP
    Rev Neurol; 2007 Jan 1-15; 44(1):15-7. PubMed ID: 17199224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HSPA5 promoter polymorphisms and risk of Parkinson's disease in Taiwan.
    Chen CM; Wu YR; Hu FJ; Chen YC; Chuang TJ; Cheng YF; Lee-Chen GJ
    Neurosci Lett; 2008 Apr; 435(3):219-22. PubMed ID: 18343577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.